Congenital heart defects (CHD) represent the most common congenital malformations globally and constitute a leading cause of neonatal mortality, with early maternal risk factors playing significant ...
UniQure’s Path for Huntington’s Gene Therapy Clouded by Ethical Questions as Potential Phase 3 Looms
While the FDA appears to be adamant that uniQure conduct a sham surgery–controlled Phase 3 trial before AMT-130 can be ...
AI Governance, Ethical AI, Healthcare Management, Bias Mitigation, Organizational Frameworks, Responsible AI Share and Cite: Grant, V. and Levasseur, R. (2026) Translating AI Ethics into Hospital ...
The law firm of Robbins Geller Rudman & Dowd LLP announces purchasers or acquirers of Ultragenyx Pharmaceutical Inc. (NASDAQ: ...
A panel of physicians, biotech leaders and patient advocates took aim at the FDA during a Senate hearing Thursday on how the ...
More babies and children survive the wait for a heart transplant than in the past, but improvements are due to better medical care, not changes to ...
Ultragenyx Pharmaceutical Inc. ( RARE) TD Cowen 46th Annual Health Care Conference March 2, 2026 1:50 PM EST ...
Heat-related ED visits for extreme heat were generally higher in early summer than in late summer, suggesting the necessity to consider temporal changes in heat risk when developing nuanced and ...
In an interview, C. Ola Landgren, MD, PhD, delved into the details of the FDA's draft guidance on using MRD as a basis for ...
Recent years have seen emergency departments (EDs) face escalating pressures due to rising patient volumes, unpredictable surges, and increasing operational ...
6dOpinion
Opinion: CT needs regulations reflecting economic, biological reality of 2026, not fears of the past
Connecticut’s legal market is artificially constrained by a limitation that neither improves safety nor reflects how cannabis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results